These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 12885429

  • 1. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand.
    Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Suto CM, Vernier JM.
    Brain Res; 2003 Aug 15; 981(1-2):85-98. PubMed ID: 12885429
    [Abstract] [Full Text] [Related]

  • 2. In vivo pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies.
    Rao TS, Reid RT, Correa LD, Santori EM, Gardner MF, Sacaan AI, Lorrain D, Vernier JM.
    Brain Res; 2003 Oct 03; 986(1-2):71-81. PubMed ID: 12965231
    [Abstract] [Full Text] [Related]

  • 3. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B, Whelan KT, Risbrough VB, Lloyd GK, Menzaghi F.
    Neuropsychopharmacology; 2003 Jul 03; 28(7):1235-46. PubMed ID: 12700710
    [Abstract] [Full Text] [Related]

  • 4. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates.
    Bontempi B, Whelan KT, Risbrough VB, Rao TS, Buccafusco JJ, Lloyd GK, Menzaghi F.
    J Pharmacol Exp Ther; 2001 Oct 03; 299(1):297-306. PubMed ID: 11561092
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
    Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Cosford ND.
    Brain Res; 2008 Oct 09; 1234():16-24. PubMed ID: 18692487
    [Abstract] [Full Text] [Related]

  • 6. Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys.
    Terry AV, Risbrough VB, Buccafusco JJ, Menzaghi F.
    J Pharmacol Exp Ther; 2002 Apr 09; 301(1):284-92. PubMed ID: 11907185
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine.
    Rao TS, Sacaan AI, Menzaghi FM, Reid RT, Adams PB, Correa LD, Whelan KT, Vernier JM.
    Brain Res; 2004 Apr 02; 1003(1-2):42-53. PubMed ID: 15019562
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
    Sacaan AI, Reid RT, Santori EM, Adams P, Correa LD, Mahaffy LS, Bleicher L, Cosford ND, Stauderman KA, McDonald IA, Rao TS, Lloyd GK.
    J Pharmacol Exp Ther; 1997 Jan 02; 280(1):373-83. PubMed ID: 8996218
    [Abstract] [Full Text] [Related]

  • 9. The subtype-selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
    Schneider JS, Tinker JP, Menzaghi F, Lloyd GK.
    J Pharmacol Exp Ther; 2003 Jul 02; 306(1):401-6. PubMed ID: 12721323
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
    Rao TS, Correa LD, Adams P, Santori EM, Sacaan AI.
    Brain Res; 2003 Nov 14; 990(1-2):203-8. PubMed ID: 14568345
    [Abstract] [Full Text] [Related]

  • 11. A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task.
    Grottick AJ, Wyler R, Higgins GA.
    Pharmacol Biochem Behav; 2001 Dec 14; 70(4):505-13. PubMed ID: 11796150
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK, Sumithran SP, Dwoskin LP.
    J Pharmacol Exp Ther; 2002 Sep 14; 302(3):1113-22. PubMed ID: 12183670
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
    Rousseau SJ, Jones IW, Pullar IA, Wonnacott S.
    Neuropharmacology; 2005 Jul 14; 49(1):59-72. PubMed ID: 15992581
    [Abstract] [Full Text] [Related]

  • 17. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB, Reuben M.
    Br J Pharmacol; 1996 Feb 14; 117(4):595-606. PubMed ID: 8646402
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.
    Tani Y, Saito K, Imoto M, Ohno T.
    Eur J Pharmacol; 1998 Jun 19; 351(2):181-8. PubMed ID: 9687001
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.